Cite
MLA Citation
Hong Zheng et al.. “A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia.” American journal of hematology, vol. 96, no. 2, 2021, pp. E46–E50. http://access.bl.uk/ark:/81055/vdc_100120032332.0x00003e